FT
GSK icon

Fiduciary Trust’s GSK GSK Stock Holding History

Fiduciary Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$934K Sell
16,915
-45
-0.3% -$2.44K 0.01% 428
2025
Q4 		$832K Sell
16,960
-59
-0.3% -$2.75K 0.01% 455
2025
Q3 		$735K Buy
17,019
+619
+4% +$24.2K 0.01% 481
2025
Q2 		$630K Buy
16,400
+580
+4% +$22.2K 0.01% 490
2025
Q1 		$613K Buy
15,820
+1,204
+8% +$44.1K 0.01% 489
2024
Q4 		$494K Sell
14,616
-3,022
-17% -$109K 0.01% 478
2024
Q3 		$721K Buy
17,638
+486
+3% +$19.9K 0.01% 421
2024
Q2 		$660K Buy
17,152
+128
+0.8% +$5.38K 0.01% 410
2024
Q1 		$730K Buy
17,024
+2,143
+14% +$88.4K 0.01% 397
2023
Q4 		$551K Buy
14,881
+569
+4% +$20.4K 0.01% 434
2023
Q3 		$519K Buy
14,312
+25
+0.2% +$887 0.01% 428
2023
Q2 		$509K Buy
14,287
+1,072
+8% +$38.5K 0.01% 439
2023
Q1 		$470K Buy
13,215
+856
+7% +$29.9K 0.01% 449
2022
Q4 		$434K Buy
12,359
+1,639
+15% +$54.6K 0.01% 477
2022
Q3 		$315K Sell
10,720
-861
-7% -$32.6K 0.01% 515
2022
Q2 		$630K Buy
11,581
+285
+3% +$15.7K 0.01% 410
2022
Q1 		$615K Hold
11,296
– – 0.01% 434
2021
Q4 		$623K Sell
11,296
-149
-1% -$7.75K 0.01% 439
2021
Q3 		$547K Hold
11,445
– – 0.01% 458
2021
Q2 		$570K Sell
11,445
-2,877
-20% -$138K 0.01% 439
2021
Q1 		$639K Hold
14,322
– – 0.01% 413
2020
Q4 		$658K Sell
14,322
-708
-5% -$32.5K 0.01% 382
2020
Q3 		$707K Sell
15,030
-5,264
-26% -$264K 0.02% 340
2020
Q2 		$1.03M Buy
20,294
+5,380
+36% +$276K 0.03% 270
2020
Q1 		$707K Sell
14,914
-392
-3% -$20.9K 0.02% 296
2019
Q4 		$899K Hold
15,306
– – 0.02% 293
2019
Q3 		$816K Buy
15,306
+8
+0.1% +$412 0.02% 298
2019
Q2 		$765K Buy
15,298
+1,092
+8% +$54.8K 0.02% 296
2019
Q1 		$742K Buy
14,206
+400
+3% +$20K 0.02% 292
2018
Q4 		$659K Hold
13,806
– – 0.02% 286
2018
Q3 		$693K Hold
13,806
– – 0.02% 296
2018
Q2 		$696K Sell
13,806
-400
-3% -$20.1K 0.02% 292
2018
Q1 		$694K Buy
14,206
+252
+2% +$11.7K 0.02% 287
2017
Q4 		$619K Sell
13,954
-3,600
-21% -$166K 0.02% 298
2017
Q3 		$891K Sell
17,554
-149
-0.8% -$7.56K 0.03% 259
2017
Q2 		$954K Hold
17,703
– – 0.03% 253
2017
Q1 		$933K Sell
17,703
-108
-0.6% -$5.48K 0.03% 261
2016
Q4 		$857K Hold
17,811
– – 0.03% 276
2016
Q3 		$960K Hold
17,811
– – 0.03% 258
2016
Q2 		$965K Sell
17,811
-2,968
-14% -$156K 0.03% 262
2016
Q1 		$1.05M Buy
+20,779
New +$1.03M 0.04% 246

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fiduciary Trust's GSK Position: Q1 2026 in Review

Fiduciary Trust reduced its GSK (GSK) stake by 0.27% in Q1 2026, selling an estimated $2.44K and leaving 16,915 shares worth $934K. The position accounts for 0.01% of the portfolio, ranked #428.

Fiduciary Trust first reported a position in GSK in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.05M in Q1 2016. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Fiduciary Trust held 16,915 shares of GSK worth $934K as of Q1 2026.
  • Fiduciary Trust sold 45 GSK shares in Q1 2026, an estimated $2.44K.
  • GSK made up 0.01% of Fiduciary Trust's portfolio in Q1 2026, its #428 holding.
  • Fiduciary Trust first reported a position in GSK in Q1 2016 and has held it in 41 quarters since.
  • Fiduciary Trust's GSK position peaked at $1.05M in Q1 2016.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.